PharVision Advisers’s B&G Foods BGS Stock Holding History

PharVision Advisers’s Portfolio BGS Stock Details BGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,238	Closed	-$346K	–	295
2024 Q4	$346K	Buy	+50,238	New	+$378K	0.29%	109

Other funds holding BGS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PharVision Advisers's BGS Position: Q1 2025 in Review

PharVision Advisers sold out of B&G Foods (BGS) in Q1 2025, closing a stake of 50,238 shares — an estimated $346K sold.

PharVision Advisers first reported a position in BGS in Q4 2024 and held it in 1 quarter. The position peaked at $346K in Q4 2024. 253 funds tracked by Wall St. Rank hold BGS as of Q1 2025.

PharVision Advisers reported no remaining B&G Foods position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 50,238 B&G Foods shares in Q1 2025, an estimated $346K.
PharVision Advisers first reported a position in B&G Foods in Q4 2024 and held it in 1 quarter.
PharVision Advisers's B&G Foods position peaked at $346K in Q4 2024.
253 funds tracked by Wall St. Rank held B&G Foods as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.